Gilead, DOJ Allowed To Redact Remaining Docs In Patent Row

By Leslie A. Pappas (April 4, 2023, 5:02 PM EDT) -- The federal government and Gilead Sciences Inc. got approval from a federal judge Tuesday to redact a limited number of documents after making public dozens of previously sealed filings in response to a third-party challenge, ahead of a May trial on their patent dispute over HIV drugs Truvada and Descovy....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!